Clene Inc.
CLNN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001822791
No open-market purchases or sales by Clene Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $19.6M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Clene Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Clene Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Matlin David J | Director | 912,275 | Sep 18, 2026 | 6 |
| Etherington Robert Dee | President & CEO | 55,393 | Sep 18, 2026 | 4 |
| Mosca Alison | Director, 10% Owner | 478,671Indirect | Sep 18, 2026 | 6 |
| Kiernan Matthew | Director | – | Aug 14, 2026 | 4 |
| Desai Arjun JJ | Director | – | Aug 14, 2026 | 4 |
| Jacobovitz Shalom | Director | 20,838 | Aug 14, 2026 | 4 |
| Gay Jonathon | Director | 105,625Indirect | Aug 14, 2026 | 4 |
| McLaughlin Vallerie | Director | – | Aug 14, 2026 | 4 |
| Wilcox Reed N | Director | 575,145 | Aug 14, 2026 | 4 |
| Ugwumba Chidozie | 10% Owner | 103,417Indirect | Aug 6, 2026 | 23 |
| Brown Morgan R | Chief Financial Officer | – | Jun 15, 2026 | 3 |
| Mortenson Mark | Chief Science Officer | 28,949 | Jun 15, 2026 | 3 |
| General Resonance LLC | 10% Owner | 704,591 | Aug 21, 2025 | 0 |
| Stevens John Henry | Director | 800,204 | Sep 19, 2023 | 0 |
| Glanzman Robert | Chief Medical Officer | 10,564 | May 18, 2022 | 0 |
| Jeong Tae Heum | Chief Finance Officer | – | Nov 4, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 19, 2022 (view filing) | Jul 18 | 1 day | Etherington Robert DeeChief Executive Officer | SSale | −23.5K | $4.72 | −$110.8K | −29.3%56.6K after | |
| Jun 21, 2022 (view filing) | Jun 16-17 | 5 days | Matlin David JDirector | PPurchase | +149.6K | $2.50 | +$374.8K | +6.6%2.42M after | 2 lots |
| Jun 17, 2022 (view filing) | Jun 16 | 1 day | Mortenson MarkChief Science Officer | SSale | −20.2K | $2.47 | −$50.0K | −10.7%168.8K after | |
| Jun 16, 2022 (view filing) | Jun 15 | 1 day | Mosca AlisonDirector | PPurchase | +5.00K | $2.62 | +$13.1K | +14.5%39.5K after | |
| Jun 16, 2022 (view filing) | Jun 14-15 | 2 days | Matlin David JDirector | PPurchase | +96.0K | $2.66 | +$255.4K | +4.4%2.27M after | 2 lots |
| Jun 14, 2022 (view filing) | Jun 13 | 1 day | Matlin David JDirector | PPurchase | +55.0K | $3.06 | +$168.3K | +2.6%2.18M after | |
| Jun 7, 2022 (view filing) | Jun 3-6 | 4 days | Matlin David JDirector | PPurchase | +60.7K | $2.55 | +$154.8K | +2.9%2.12M after | 2 lots |
| May 27, 2022 (view filing) | May 27 | Same day | Matlin David JDirector | PPurchase | +35.0K | $2.27 | +$79.5K | +1.7%2.06M after | |
| May 18, 2022 (view filing) | May 16 | 2 days | Matlin David JDirector | PPurchase | +181.8K | $2.20 | +$400.0K | +9.9%2.03M after | |
| May 18, 2022 (view filing) | May 16 | 2 days | Glanzman RobertChief Medical Officer | SSale | −4.72K | $2.03 | −$9.58K | −30.9%10.6K after | |
| May 18, 2022 (view filing) | May 16 | 2 days | General Resonance LLC10% Owner | SSale | −181.8K | $2.20 | −$400.0K | −1.2%15.6M after | |
| May 17, 2022 (view filing) | May 16 | 1 day | Gay JonathonDirector | PPurchase | +10.0K | $2.08 | +$20.8K | +17.0%68.7K after | |
| Apr 22, 2022 (view filing) | Apr 21 | 1 day | General Resonance LLC10% Owner | SSale | −132.9K | $3.01 | −$400.0K | −0.8%15.7M after | |
| Apr 21, 2022 (view filing) | Apr 20 | 1 day | Matlin David JDirector | PPurchase | +132.9K | $3.01 | +$400.0K | +7.8%1.84M after | |
| Mar 30, 2022 (view filing) | Mar 28-29 | 2 days | Matlin David JDirector | PPurchase | +18.6K | $3.16 | +$58.9K | +1.1%1.71M after | 2 lots |
| Mar 25, 2022 (view filing) | Mar 23-24 | 2 days | Matlin David JDirector | PPurchase | +40.0K | $2.97 | +$118.6K | +2.4%1.69M after | 2 lots |
| Mar 22, 2022 (view filing) | Mar 18-21 | 4 days | Matlin David JDirector | PPurchase | +55.0K | $2.86 | +$157.3K | +3.4%1.65M after | 2 lots |
| Feb 3, 2022 (view filing) | Feb 1 | 2 days | General Resonance LLC10% Owner | SSale | −101.4K | $2.96 | −$300.0K | −0.6%15.9M after | |
| Feb 2, 2022 (view filing) | Feb 1 | 1 day | Matlin David JDirector | PPurchase | +101.4K | $2.96 | +$300.0K | +6.8%1.60M after | |
| Dec 10, 2021 (view filing) | Dec 8-10 | 2 days | Matlin David JDirector | PPurchase | +60.0K | $4.96 | +$297.7K | +4.2%1.50M after | 3 lots |
| Nov 17, 2021 (view filing) | Nov 16 | 1 day | Matlin David JDirector | PPurchase | +20.0K | $5.26 | +$105.2K | +1.4%1.42M after | |
| Nov 15, 2021 (view filing) | Nov 12-15 | 3 days | Matlin David JDirector | PPurchase | +25.0K | $5.57 | +$139.3K | +1.8%1.40M after | 2 lots |